2-es típusú cukorbetegség: vizsgálatok itt: Finnország
3 of 11 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Helsinki
- Életkor
- 18 év to 99 év
- People
- 24 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - No phaseTaking peopleThe European NAFLD Registry
- Where
- Helsinki
- Életkor
- 18 év to 100 év
- People
- 10 000 worldwide
- Run by
- Newcastle University
See details and how to joinNCT04442334 - No phaseCsak meghívásosCost-effectiveness of the Care Pathways
- Where
- Tampere
- Életkor
- 18 év to 90 év
- People
- 2500
- Run by
- Tampere University Hospital
See details and how to joinNCT04619836